Molecular Radiotherapy and Therapeutic Innovation

This team belongs to the UMR 1030 - Molecular radiotherapy and therapeutic innovations

Our team is composed of 2 groups:

• The Cell death, Immunity and Therapeutic Innovation group led by Dr. Jean-Luc PERFETTINI
• The Radiotherapy, ImmunoRadAI group led by Pr. Eric DEUTSCH

The REMISSION program was granted by the 6^th call for projects of the Hospital-University Research (RHU) endeavor of the France 2030 government investment plan. It proposes to use fresh tissues (blood and tumor) as a source of biomarkers to adapt new immunotherapy strategies to the biology of patients and their cancer. This program aligns with Gustave Roussy's objectives to personalize treatments for cancer patients.

Chromatin function in DNA repair

Contacts

Beatrice Rondinelli
ATIP/Avenir team “Chromatin function in DNA repair"
Genome Integrity & Cancers
UMR9019 – CNRS Paris-Saclay
GUSTAVE ROUSSY  - PR2, Room 401
114, rue Edouard Vaillant
94805 - Villejuif Cedex
FRANCE
Email : beatrice.rondinelli@gustaveroussy.fr

Chromatin function in DNA repair

Chromatin function in DNA repair

This group belongs to the UMR 9019 Genome Integrity and Cancers.

CARE1: A European Study on First-Line Treatment of Metastatic Kidney Cancer

LySAIRI: towards an innovative radiotherapy that facilitates immune sparing to improve overall clinical efficacy

Laurie Menger

Biography

Clinical Transfer Imaging - Team members

Scientific manager: Ingrid Breuskin (MD, PhD)

Operational manager: Muriel Abbaci (PhD)
Tel. 01.42.11.60.15
muriel.abbaci@gustaveroussy.fr

Valérie Rouffiac (PhD)
Tel. 01.42.11.64.61
 valerie.rouffiac@gustaveroussy.fr